These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15906304)

  • 41. Clinical 1H magnetic resonance spectroscopy of brain metastases at 1.5T and 3T.
    Sjøbakk TE; Lundgren S; Kristoffersen A; Singstad T; Svarliaunet AJ; Sonnewald U; Gribbestad IS
    Acta Radiol; 2006 Jun; 47(5):501-8. PubMed ID: 16796315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study.
    Scheidler J; Hricak H; Vigneron DB; Yu KK; Sokolov DL; Huang LR; Zaloudek CJ; Nelson SJ; Carroll PR; Kurhanewicz J
    Radiology; 1999 Nov; 213(2):473-80. PubMed ID: 10551229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human prostate: multisection proton MR spectroscopic imaging with a single spin-echo sequence--preliminary experience.
    van der Graaf M; van den Boogert HJ; Jager GJ; Barentsz JO; Heerschap A
    Radiology; 1999 Dec; 213(3):919-25. PubMed ID: 10580976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue.
    Heerschap A; Jager GJ; van der Graaf M; Barentsz JO; de la Rosette JJ; Oosterhof GO; Ruijter ET; Ruijs SH
    Anticancer Res; 1997; 17(3A):1455-60. PubMed ID: 9179183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching.
    Scheidler J; Vogel M; Gross P; Heuck A
    Rofo; 2009 Jun; 181(6):531-5. PubMed ID: 19353482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.
    Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W
    Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
    Testa C; Schiavina R; Lodi R; Salizzoni E; Corti B; Farsad M; Kurhanewicz J; Manferrari F; Brunocilla E; Tonon C; Monetti N; Castellucci P; Fanti S; Coe M; Grigioni WF; Martorana G; Canini R; Barbiroli B
    Radiology; 2007 Sep; 244(3):797-806. PubMed ID: 17652190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology.
    Styles C; Ferris N; Mitchell C; Murphy D; Frydenberg M; Mills J; Pedersen J; Bergen N; Duchesne G
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):439-48. PubMed ID: 24935089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimizing PRESS localized citrate detection at 3 Tesla.
    Trabesinger AH; Meier D; Dydak U; Lamerichs R; Boesiger P
    Magn Reson Med; 2005 Jul; 54(1):51-8. PubMed ID: 15968673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology.
    García-Segura JM; Sánchez-Chapado M; Ibarburen C; Viaño J; Angulo JC; González J; Rodríguez-Vallejo JM
    Magn Reson Imaging; 1999 Jun; 17(5):755-65. PubMed ID: 10372529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
    García-Martín ML; Adrados M; Ortega MP; Fernández González I; López-Larrubia P; Viaño J; García-Segura JM
    Magn Reson Med; 2011 Feb; 65(2):329-39. PubMed ID: 20939087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging.
    Kaji Y; Kurhanewicz J; Hricak H; Sokolov DL; Huang LR; Nelson SJ; Vigneron DB
    Radiology; 1998 Mar; 206(3):785-90. PubMed ID: 9494502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SELOVS: brain MRSI localization based on highly selective T1- and B1- insensitive outer-volume suppression at 3T.
    Henning A; Schär M; Schulte RF; Wilm B; Pruessmann KP; Boesiger P
    Magn Reson Med; 2008 Jan; 59(1):40-51. PubMed ID: 18050349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
    Hom JJ; Coakley FV; Simko JP; Lu Y; Qayyum A; Westphalen AC; Schmitt LD; Carroll PR; Kurhanewicz J
    Radiology; 2007 Feb; 242(2):483-9. PubMed ID: 17179396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of pulse angle variations on stimulated echo acquisition mode proton nuclear magnetic resonance spectra of AB spin systems: theory and experiments with citrate.
    Straubinger K; Schick F; Lutz O
    MAGMA; 1998 Dec; 7(2):88-94. PubMed ID: 9951769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin-echo pulse sequence.
    Heerschap A; Jager GJ; van der Graaf M; Barentsz JO; Ruijs SH
    Magn Reson Med; 1997 Feb; 37(2):204-13. PubMed ID: 9001144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo MR spectroscopic imaging of the prostate, from application to interpretation.
    Tayari N; Heerschap A; Scheenen TWJ; Kobus T
    Anal Biochem; 2017 Jul; 529():158-170. PubMed ID: 28167072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
    Fütterer JJ; Heijmink SW; Scheenen TW; Veltman J; Huisman HJ; Vos P; Hulsbergen-Van de Kaa CA; Witjes JA; Krabbe PF; Heerschap A; Barentsz JO
    Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.